Literature DB >> 10469431

Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders.

J C Carey1, D H Viskochil.   

Abstract

Neurofibromatosis type 1 (NF1) is a pleiotropic autosomal dominant disorder with marked variability of clinical expression. As in other heritable disorders, the mapping and cloning of the gene responsible for NF1 have increased our understanding of the pathogenesis of the condition. In particular, the phenotypic variability and variable expressivity can be studied using molecular techniques. In this article we summarize the current knowledge of genotype/phenotype correlation in NF1 and examine the potential molecular basis for variable expressivity. Am. J. Med. Genet. (Semin. Med. Genet.) 89:7-13, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10469431

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

Review 2.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

3.  The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.

Authors:  Ryo Maruoka; Toshiki Takenouchi; Chiharu Torii; Atsushi Shimizu; Kumiko Misu; Koichiro Higasa; Fumihiko Matsuda; Arihito Ota; Katsumi Tanito; Akira Kuramochi; Yoshimi Arima; Fujio Otsuka; Yuichi Yoshida; Keiji Moriyama; Michihito Niimura; Hideyuki Saya; Kenjiro Kosaki
Journal:  Genet Test Mol Biomarkers       Date:  2014-10-17

4.  Diagnostic yield and clinical impact of exome sequencing in early-onset scoliosis (EOS).

Authors:  Sen Zhao; Yuanqiang Zhang; Weisheng Chen; Weiyu Li; Shengru Wang; Lianlei Wang; Yanxue Zhao; Mao Lin; Yongyu Ye; Jiachen Lin; Yu Zheng; Jiaqi Liu; Hengqiang Zhao; Zihui Yan; Yongxin Yang; Yingzhao Huang; Guanfeng Lin; Zefu Chen; Zhen Zhang; Sen Liu; Lichao Jin; Zhaoyang Wang; Jingdan Chen; Yuchen Niu; Xiaoxin Li; Yong Wu; Yipeng Wang; Renqian Du; Na Gao; Hong Zhao; Ying Yang; Ying Liu; Ye Tian; Wenli Li; Yu Zhao; Jia Liu; Bin Yu; Na Zhang; Keyi Yu; Xu Yang; Shugang Li; Yuan Xu; Jianhua Hu; Zhe Liu; Jianxiong Shen; Shuyang Zhang; Jianzhong Su; Anas M Khanshour; Yared H Kidane; Brandon Ramo; Jonathan J Rios; Pengfei Liu; V Reid Sutton; Jennifer E Posey; Zhihong Wu; Guixing Qiu; Carol A Wise; Feng Zhang; James R Lupski; Jianguo Zhang; Nan Wu
Journal:  J Med Genet       Date:  2020-05-07       Impact factor: 6.318

5.  Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.

Authors:  Alexander Pemov; Heejong Sung; Paula L Hyland; Jennifer L Sloan; Sarah L Ruppert; Andrea M Baldwin; Joseph F Boland; Sara E Bass; Hyo Jung Lee; Kristine M Jones; Xijun Zhang; James C Mullikin; Brigitte C Widemann; Alexander F Wilson; Douglas R Stewart
Journal:  PLoS Genet       Date:  2014-10-16       Impact factor: 5.917

6.  Generalized metabolic bone disease in Neurofibromatosis type I.

Authors:  Nicola Brunetti-Pierri; Stephen B Doty; John Hicks; Kelly Phan; Roberto Mendoza-Londono; Maria Blazo; Alyssa Tran; Susan Carter; Richard Alan Lewis; Sharon E Plon; William A Phillips; E O'Brian Smith; Kenneth J Ellis; Brendan Lee
Journal:  Mol Genet Metab       Date:  2008-03-04       Impact factor: 4.797

7.  Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.

Authors:  Heejong Sung; Paula L Hyland; Alexander Pemov; Jeremy A Sabourin; Andrea M Baldwin; Sara Bass; Kedest Teshome; Wen Luo; Brigitte C Widemann; Douglas R Stewart; Alexander F Wilson
Journal:  Mol Genet Genomic Med       Date:  2020-08-31       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.